Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Global Indemnity posts $8.3M Q1 operating income, showing strong underwriting profit and 5.4% premium growth.

Company Fundamentals
05 May 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Global Indemnity Group reported a Q1 2026 operating income of $8.3 million, reversing a loss from the previous year, driven by a 5.4% increase in net earned premiums and a stable combined ratio of 94.9%. The company’s underwriting income grew 4% excluding wildfire impacts, reflecting solid underwriting performance and disciplined pricing despite competitive market conditions. Investment income declined slightly due to market factors but is expected to recover. The company maintains a strong capital position with $700.1 million in shareholders' equity and continues to return value to shareholders through dividends and share repurchases.

More News

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom reports record Q1 revenue growth of 56%, raises full-year outlook, and plans acquisition to boost data center services.

Dycom Industries reported a record first quarter with contract revenues up 56.1% to $1.965 billion and adjusted net income nearly doubling to $134.3 million. The company raised its full-year fiscal 2027 revenue outlook to $7.38-$7.65 billion, driven ...

Company Fundamentals
Bullish
20 minutes ago
BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog launches UK-wide summer campaign with beer giveaways and football watch parties

BrewDog, part of Tilray Brands, is rolling out a major summer campaign across the UK tied to the global football tournament. The campaign features a "Win a Year of Beer" contest with special cans hidden in over 2.8 million packs at major retailers, p...

Market News
Bullish
20 minutes ago
Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics to present at two investor conferences in early June 2026

Autolus Therapeutics, a biopharmaceutical company specializing in next-generation T cell therapies, announced it will present at two upcoming investor conferences: William Blair’s Growth Stock Conference on June 2 and Jefferies Global Healthcare Conf...

Market News
Neutral
20 minutes ago
Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharma shows low drug interaction risk for new Hepatitis C treatment and promising Hepatitis E antiviral data.

Atea Pharmaceuticals announced Phase 1 results indicating their Hepatitis C treatment regimen, combining bemnifosbuvir and ruzasvir, has a low risk of drug-drug interactions with common medications like omeprazole and rosuvastatin. This supports easi...

Market News
Bullish
20 minutes ago
Law firm probes Capital One stock drop post-Discover acquisition, urges affected investors to seek compensation

Law firm probes Capital One stock drop post-Discover acquisition, urges affected investors to seek compensation

Girard Sharp LLP is investigating potential securities claims for former Discover investors who received Capital One shares after Capital One acquired Discover in May 2025. Since the merger, Capital One's stock price has declined, leading to possible...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App